Literature DB >> 35186677

Artesunate inhibits proliferation and migration of RPE cells and TGF-β2 mediated epithelial mesenchymal transition by suppressing PI3K/AKT pathway.

Zi-Yi Wang1, Yu Zhang1, Ling-Dan Wu1, Jie Chen1, Mei-Ling Chen1, Ci-Min Chen1, Qi-Hua Xu1.   

Abstract

AIM: To study the braking effectiveness of artesunate on transforming growth factor (TGF)-β2 mediated epithelial-mesenchymal transition (EMT) in retinal pigment epithelium (RPE) in vitro.
METHODS: The fostered ARPE-19 cells were processed with artesunate alone or combined with the TGF-β2. The CCK-8 examination was utilized to test the cell propagation. Cell migration was detected by scratch as well as the Transwell examination. The EMT characters and activation of PI3K/Akt signal channel were estimated by Western blotting and immunofluorescence. The Western blotting was utilized in order to confirm the vitreous of controls as well as patients with proliferative vitreoretinopathy (PVR) were collected and the levels of PI3K, phospho-PI3K, Akt.
RESULTS: Disposal of ARPE-19 cells with artesunate (50-150 µmol/L) obviously suppressed their propagation and immigration, which dependent on the concentration and time. Artesunate suppressed the EMT which was induced by TGF-β2 in ARPE-19 cells through sustaining the expression of vimentin and α-SMA through the suppression of PI3K, phospho-PI3K, phospho-Akt and Akt. Levels of PI3K, phospho-PI3K, AKT and phospho-Akt was increased in the vitreous in PVR (P<0.05).
CONCLUSION: Such findings indicate that PI3K/Akt signal channel is highly activated in vitreous of PVR. Artesuante is an operative depressor of the propagation, immigration and TGF-β2-mediated EMT of ARPE-19 cells by reduced the expression of PI3K/Akt channel. International Journal of Ophthalmology Press.

Entities:  

Keywords:  artesunate; epithelial-mesenchymal transition; migration; proliferative vitreoretinopathy

Year:  2022        PMID: 35186677      PMCID: PMC8818474          DOI: 10.18240/ijo.2022.02.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  26 in total

Review 1.  Use of artesunate in non-malarial indications.

Authors:  A Raffetin; F Bruneel; C Roussel; M Thellier; P Buffet; E Caumes; S Jauréguiberry
Journal:  Med Mal Infect       Date:  2018-02-13       Impact factor: 2.152

2.  Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.

Authors:  Yanyan Zhao; Weiwei Jiang; Bin Li; Qi Yao; Junqing Dong; Yanyan Cen; Xichun Pan; Jun Li; Jiang Zheng; Xueli Pang; Hong Zhou
Journal:  Int Immunopharmacol       Date:  2011-09-09       Impact factor: 4.932

3.  Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation.

Authors:  Bin Li; Jun Li; Xichun Pan; Guofu Ding; Hongwei Cao; Weiwei Jiang; Jiang Zheng; Hong Zhou
Journal:  Int Immunopharmacol       Date:  2009-12-11       Impact factor: 4.932

Review 4.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Authors:  Hetian Lei; Marc-Andre Rheaume; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2009-11-25       Impact factor: 3.467

5.  The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte.

Authors:  Ya He; Jinjin Fan; Haobo Lin; Xiuyan Yang; Yujin Ye; Liuqin Liang; Zhongping Zhan; Xiuqing Dong; Lin Sun; Hanshi Xu
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

Review 6.  The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR.

Authors:  Zhenna Chen; Yan Shao; Xiaorong Li
Journal:  Mol Vis       Date:  2015-06-24       Impact factor: 2.367

7.  Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K/AKT/mTOR signaling pathways in PVR.

Authors:  Haiting Chen; Huifang Wang; Jianbin An; Qingli Shang; Jingxue Ma
Journal:  BMC Complement Altern Med       Date:  2018-03-13       Impact factor: 3.659

8.  PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway.

Authors:  Zhan Ma; Shuping Lou; Zheng Jiang
Journal:  Aging (Albany NY)       Date:  2020-05-08       Impact factor: 5.682

9.  Role of artesunate in TGF‑β1‑induced renal tubular epithelial‑mesenchymal transdifferentiation in NRK‑52E cells.

Authors:  Yaqian Zhang; Huanhuan Li; Jiajun Zhu; Tiantian Wei; Yingxian Peng; Ran Li; Rui Xu; Mei Li; Anzhou Xia
Journal:  Mol Med Rep       Date:  2017-10-05       Impact factor: 2.952

10.  RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy.

Authors:  Xiaohua Li; Mingwei Zhao; Shikun He
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.